February 2, 2017

DSN senior editor Michael Johnsen takes a deep dive into one of the most strategically important categories in retail pharmacy.

February 2, 2017

The UR nasal subcategory saw impressive growth in the channels studied, due in large part to the recent Rx-to-OTC switch products in the nasal corticosteroid segment, driving sales up 15% in the food industry and up to10% in drug.

February 2, 2017

The emergence of new products across the cough-cold and allergy categories is transforming the OTC aisle.

February 1, 2017

Xyzal is an antihistamine containing the active ingredient levocetirizine dihydrochloride and provides 24-hour relief from runny nose, sneezing, itchy watery eyes and itching of the nose or throat in a single daily dose.

January 19, 2017

"There are already a number of laws ... that help to fight the meth problem in Michigan," CHPA stated, "including the NLPE which serve as strong barriers to meth makers [obtaining] PSE."

January 4, 2017

RB is in search of Indiegogo campaigners whose innovations specifically fit within the following focus categories: respiratory, pain relief, health monitoring, sexual well-being and vitamins, minerals and supplements.

October 20, 2016

Read about and see photos of GSK Consumer Healthcare’s state-of-the-art Innovation Labs at the company’s new headquarters in Warren, N.J. 

October 17, 2016

DSN senior editor Michael Johnsen examines in-depth sales activity in the analgesic and digestive aisles, highlighting products that are transforming OTC, in this multi-page report.

September 22, 2016

More than 5,000 Americans across the country participated in the online survey, which awards the “Reader’s Digest Most Trusted Brand” title to winners in 40 product categories.

September 7, 2016

The allergy space will continue to heat up significantly in 2017 as marketers pollinate the airwaves with advertisements promoting their latest brand introductions

September 7, 2016

As many as 71% of U.S. households (85 million) suffer from sinus symptoms in a given year, while 17% of U.S. households (20 million) are severe sinus sufferers.

September 6, 2016

DSN senior editor Michael Johnsen examines in-depth sales activity in the homeopathy aisles, highlighting products that are transforming OTC, and catches up with Pharmavite's Tim Toll to talk VMS, in this multi-page report.

August 24, 2016

The merchandisers completed an extensive, multi-module training program over the course of several months, earning certification from HRG experts.

August 3, 2016

Previously available by prescription as Veramyst, Flonase Sensimist is the latest Rx-to-OTC switch from GSK.

August 3, 2016

DSN senior editor Michael Johnsen examines what's trending now overall in OTC aisles, as well as in-depth sales activity in the allergy; vitamins, minerals and supplements; eye care; wearables; incontinence; adult nutrition; and lice treatment categories, highlighting products that are transforming OTC, in this multi-page report.

August 2, 2016

Sales of OTC medicines continue on a steady pace with dollar volumes up half a billion dollars over the first half of 2016, according to data culled from IRI.

August 2, 2016

In March, GSK Consumer Healthcare launched Children’s Flonase, which blocks six allergic substances, reduces inflammation and relieves allergy symptoms caused by pollen, mold spores, dust mites and pet dander.

August 2, 2016

Sales across the overall eye care and contact lens care categories generated $1.8 billion across total U.S. multi-outlets for the period ended May 15, representing growth of 2.4%.

August 2, 2016

GSK Consumer Healthcare’s Flonase allergy remedy was the single greatest generator of incremental dollars for the 52 weeks ended May 15 across total U.S. multi-outlets, according to IRI data, with $345.2 million in sales on 209.9% growth.

August 2, 2016

The 2016 spring allergy season was expected to be the worst allergy season ever.

July 29, 2016

GNC Holdings on Thursday replaced its chief executive and suspended its earnings guidance. It also reported disappointing second quarter results.

July 26, 2016

Online and other non-store sales, which are included in the overall figure, are expected to increase 7% to 10% year-over-year rather than the 6% to 9% percent forecast earlier.

July 25, 2016

Market leaders Johnson & Johnson and Bayer have remained the No. 1 and No. 2 OTC marketers, respectively, for many years.

July 13, 2016

Led by NCPA's senior director of store operations and marketing Gabe Trahan, the Front-End Profit Building Seminar is a one-day program that gives owners the tools and knowledge to increase store traffic and profits.